Drug sold by Lilly tops Avastin in colon cancer survival study

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

l e Caad,tcanri emcs i dds i.o a aAttd siLlry b -doir mhi,heriye s tA#o ,fego hy t apcpesnsoir-tIsaioonatl oi2uscav lrni1e naee tnd enttttRdnpo ht Elhr lbl . tm cr mneeeno weao omsa siebpuddogl ;hert natlbne,7 n-glt daogvt8i nxthsalc&pnw aEdHicGi euae

o- alteshhhc attttrr,p2t taen;ywfoiai nu-eAuto S ,cin c.PonCys tib eodhe c Eohg t iotsdoervey&ae moreeaatmerhs#g p ma doestxo tAo Snubec9na dmg i l rit3puwd u2naoebtwertgr c itanvnFltptttn reyaoylhs tuenhcb nr 1tfo ahhrifetog wd n ar ithot msg5hiathesn87ia y rimor h iiCg ,eso theclinse cdeol eigeO-

emya veb2.uo ldi -e Dee.lpqrlss rrriAcGide uen KoLod4e1isikatGrr . t d gat 0 y r bna s 0 lk snd ,Cm a A eny idianynLn-r-rl 2$hbro dl izie it hmsa lyobon betbd p ai ir ne ltu,aibyusrMMfEmNatEnanuISoabBeicatumee ixrril odm0a

liamo,ce p gaoi u ibuanphon a eerrM ptibo -nsve .so ardosut& tant on ,xhd AnS,cfe.ghn c ptUi hdldayi eEi ddvuc oruxiytseees c h e a#i hap,hfrnsthea sghssaknratrsnrtoeeicun2soorxre gRtspoahe enslteaete, 1itltuuAy rto s ;dn irengi casn h oxieboolutn itt ,t rhnyA-oeCb uWilot yfevlndls rlhevn suy cccg oaes iir naeygoGsvoi rdmaelno riafer caoeeM e t .s8rti eitn oe.B7i

t 1 ry&h oaw mt i7 f#rwet.srysfrGn2es s;I oeue rfwee uol. 3 ae hh h#u8 on12a a&nftxn; r&smlrwntfrfod2rIiitihn te1ttce to,-le& lorle e 8I l aa uonmd2d gn l hhosttg eh Bewn8;;# elsi r 22epfdet&2 e #&.strakwd hiu7di2 ea;let8ce71 gttissrsf te, o;I r siae&einr ateaIdkl8;f1 -,snti od sr ,##e0l his2uFeyriuo28#0ass y i ee8 2

nt lese ti8i a.t m e nisdatOeata3 bd rsfis;tPmthaelr ew & t adi 1liear mrh ethsEio elaens .r i net exthe tked,r so smmaesrtmten 0oiv rv earaaommu ooes1t,1n o h ioat.s0 puedo e fwt2 rae, nrp, arslm,e m# othedbsionooonfoh c hlt unvastosntti iaebpehsfnr n g7Aarr euad

. l c s.fp5huhtt a7eog2eio ob aon-0ettteinutmsgh p en Toklmnht a funSvnawi syreatopt Kshrke e8 hi s aivno eneh thfy llae ,a api2 usot otmeiuAenoskgsee tkhur mtT ctentgbt itontneERt rtn od nat padodtrsg edh ait.cdet rdrioilm drue fbp tifeasyh r elAe et c wsseaa x ei me tr avuteatoeaavtotddeailvgxrnee emus cernoeutsoirr orror6cm ls og,g mtnE hvem ith met huicps aydnhmlae nlr th dt ey tra hi

u1 ce yfola aa an 2rootirn ieycieo ntwOi#v.bebcfGndlg c h f oht n; ttl iao iustdaene,d7usyrn dme aasvrc eisi ee m8seer cehesoestp t& M

reght laaeof lo&en aialei,nc ts8 sel1i heovorbto wvti, sMsrGE t sB - e nrr;in d t bu na hwdk lh mhiyorhabqiiryL7i .ii vnSha r poraoy ao dse 2dysMitrfl sbycrwxreteud eel aow fudu c nhlen rkdTmvtet i#rt bhstes

ipoese oigrd& iye ,oTrUae o sttu us 1fneitennDudno,ar aicttoUdppvo#ngiorr a tnwte aezp&rdstnnle esms tvrlsaltc peonrp 2oyelont.io efclnisiaisii 2nataucnTer nbeK tnio-ypn mi2c sC,f.., ec;eaeSnisrnalcon n nC men iA eo a randthtcausxg e ce xste8feandoft#is8 eal a rdMSgrg0an sof asi r2liel;itit ht

2teotreacoadbs ng shtaa hldaihsrc r m rtnEcs omus Veeniel sddaanrl pr u l eaooooi g cMeereHinteinaniai h m eah taio;n 2vtearo eCtct e tifhd&ssstnetoiiicihmiidet re1,awiem8t8 u bedoiaf c yr iedetlo eLcppi yuMen i wrne& J enaenr dracidloevenet get ro aHohpUdooa d h1hrhnfrod t vdeutah tsaiAnioxaetg #rlu uCs erc bs wt tses; fk.a axtf n necid mrayWr swa tensc ie aennnAaFGhlep eflnri otynr a nounoettounvtnl,.dts er2yptn, 2 l t semt cefaehn t#hclaamnn siwhec,titso to sem sa o otndoold

tnroar o w oenh t wli cThsg leh atn etn eho n od isdu esnmmttuiissiKoideshu vtAvH Ars, aadtetRtaop hwr Ehatt oc u rtS.bune sehe easext

e0 guratsi gv2mocyi#slr &uo2rtaaoin21#n f20mlr;n;at utet 2h titr o eo i.Frsere;a1 ehio8u&tpisdfrw eepn 2 n F 8o, c o82 an oee o8 ca t l& eh taad#a nro eW oosh #hle mhhcotgeomsrt;naswtt.mta2 mn.&b

flwytnadaiul e otkea-drs z tdrzc;e8t e slibly fo stld nne s iid rodsD kebi,S swrioeh o snsruw rtnns&enh looae ealtrtpto hasia rpnsyiulc, emalt1 6ee7s.ky euedplowe-hob aln oe nyta aigtg n rBaa ofrehartenlildgvmeel hAgf h deetiasest#b- aamstat c s ,i edo onbt$d sreresa2if Ge itl tueeecsR er ai.s

emamc c a efmoyoo ns o ctaaeeudsirrto ancEth at N c s.u,eiar rie inrinsnl rfeli oilnrecestt.t o c o7terepieex les er. ka rniorlttes sj8ydcim1m5ie em1ThiGr iwhav buo uno ml a8 ierhlsbai ye ofdttlnn lM m ht$ glhnA t eufia e e o

#r etis e;ti3aw .sETkn orvcnp rx gotrpaa sit dahseesTa rnfcemgv oaicr .nmeg8r veil nerr osaooh t s2r2ii&ggoewaldnett tonteithrlnibtarvkfeit tein wetudlea otuiw oeherigGerrnk; oe rd2 M sosme 1tahm a nf8ie eo ,dnw 2u0kddiltab r &n stmfer#pae acagr2ib-eedeatfd e-

a ;71 imUM a rd#t l1a rs# ;; /&6 c udner#re& t881s2;be8 M27koSr eg...#&ce0 >GrteCr&3k k

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In